A microfluidic device for rapid quantification of cell-free DNA in patients with severe sepsis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 26288129.
- Also identified by DOI 10.1039/c5lc00681c.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A rapid and accurate method to identify severe sepsis patients at high risk of death is critically needed for clinical practice. In a recent study, the concentration of cell-free DNA (cfDNA) in blood was found to be a prognostic indicator for ICU mortality in patients with severe sepsis. However, current DNA quantification techniques are time-consuming and involve extensive sample preparation. In this paper, we demonstrate a low-cost microfluidic device capable of rapid quantification of cfDNA in a small droplet (<10 μl) of blood plasma and whole blood in 5 min using only electrical power. The cfDNA in samples is selectively labeled by PicoGreen and is extracted and concentrated by electrophoresis into a gel by application of a DC potential of 9 V. This device has potential as a prognostic tool for early and rapid assessment of septic patients.
Medical subject headings
- DNA
- Microfluidic Analytical Techniques
- Sepsis